M. Niewolna

Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.

K. Mohammad, F. Luciani, L. Larue, 2007, Cancer research.

Pp60 c‐src expression and activity in MG‐63 osteoblastic cells modulated by PTH but Not required for PTH‐mediated adenylate cyclase response

T. Yoneda, G. Mundy, B. Boyce, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.

T. Yoneda, G. Mundy, T. Michigami, 2000, Blood.

Herbimycin A, a tyrosine kinase inhibitor, impairs hypercalcemia associated with a human squamous cancer producing interleukin‐6 in nude mice

Paul J. Williams, T. Yoneda, K. Moriyama, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Use of bisphosphonates for the treatment of bone metastasis in experimental animal models.

Paul J. Williams, T. Yoneda, T. Michigami, 1999, Cancer treatment reviews.

Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.

T. Yoneda, Y. Uehara, G. Mundy, 1993, The Journal of clinical investigation.

Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis.

Paul J. Williams, T. Yoneda, G. Mundy, 2004, Blood.

Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo

A. Marks, K. Mohammad, T. Guise, 2016, Oncotarget.

Hormonal regulation of pp60c-src expression during osteoclast formation in vitro.

T. Yoneda, G. Mundy, E. Izbicka, 1993, Molecular endocrinology.